Market Risers: Flowtech Fluidpower PLC, Direct Line Insurance Group PLC, DS Smith plc, Experian plc, Ferguson Plc & GlaxoSmithKline plc

Flowtech Fluidpower Plc
[shareaholic app="share_buttons" id_name="post_below_content"]

Shares in Flowtech Fluidpower PLC ticker lookup code: LON:FLO has risen 3.51% or 3.75 points throughout the session so far. Traders have remained positive during this period. The high for the period has reached 110.5 dipping to 109.75. Volume total for shares traded during this period was 8,913 with the daily average number around 140,414. A 52 week high for the stock is 195 amounting to 88.25 points in difference to the previous days close of business and a 52 week low sitting at 95.81 a difference of some 10.94 points. Flowtech Fluidpower PLC has a 20 SMA of 116.94 and a 50 day MA at 120.08. Market capitalisation for the company is £67.31m at the time of this report. The stock is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Flowtech Fluidpower PLC being recorded at Tuesday, April 2, 2019 at 11:59:41 AM GMT with the stock price trading at 110.5 GBX.

 

The stock price for Direct Line Insurance Group PLC EPIC code: LON:DLG has stepped up 1.18% or 4.2 points during the course of today’s session so far. Traders have remained positive throughout the trading session. Range high for the period has seen 361.38 dipping to 356.9. The number of shares traded by this point in time totalled 1,279,300 whilst the average number of shares exchanged is 4,364,216. The 52 week high for the shares is 386.6 around 30.7 points difference from the previous days close and putting the 52 week low at 300.66 which is a difference of 55.24 points. Direct Line Insurance Group PLC now has a 20 SMA of 358.53 with a 50 day moving average at 351.69. This puts the market capitalisation now at £4,951.38m at the time of this report. All share prices mentioned for this stock are traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Direct Line Insurance Group PLC being recorded at Tuesday, April 2, 2019 at 12:02:29 PM GMT with the stock price trading at 360.1 GBX.

 

Shares in DS Smith plc EPIC code: LON:SMDS has increased 1.24% or 4.26 points throughout today’s trading session so far. Traders have stayed positive throughout the session. The high for the period has peaked at 348.85 and hitting a low of 344.9. The volume total for shares traded up to this point was 1,206,808 with the average number of shares traded daily being 6,623,942. The 52 week high for the share price is 542.45 some 198.45 points difference from the previous days close and putting the 52 week low at 285.83 a difference of some 58.17 points. DS Smith plc now has a 20 SMA at 348.52 and now the 50 day moving average of 345.96. The market capitalisation is now £4,773.64m at the time of this report. The currency for this stock is Great British pence.Market cap is measured in GBP. This article was written with the last trade for DS Smith plc being recorded at Tuesday, April 2, 2019 at 12:03:38 PM GMT with the stock price trading at 348.26 GBX.

 

Shares in Experian plc EPIC code: LON:EXPN has climbed 1.59% or 33.22 points in today’s trading session so far. Investors are a positive bunch during the trading session. Range high for the period so far is 2130 dipping to 2104. The number of shares traded by this point in time totalled 265,804 while the daily average number of shares exchanged is 1,540,663. A 52 week high for the stock is 2130 which comes in at 36 points in difference on the previous days close and a 52 week low being 1494.5 which is a variance of 599.5 points. Experian plc has a 20 day moving average of 2047.74 and a 50 day simple moving average now at 2017.12. Market capitalisation for the company is £19,358.11m at the time of this report. The currency for this stock is GBX. Market cap is measured in GBP. This article was written with the last trade for Experian plc being recorded at Tuesday, April 2, 2019 at 12:02:48 PM GMT with the stock price trading at 2127.22 GBX.

 

Stock in Ferguson Plc company symbol: LON:FERG has climbed 1.47% or 73 points during the course of today’s session so far. Buyers have stayed positive throughout the trading session. The period high has peaked at 5040 and a low of 4984. The amount of shares exchanged has so far reached 174,196 while the daily average number of shares exchanged is 738,671. The 52 week high for the share price is 6601 some 1640 points different to the previous business close and a 52 week low sitting at 4594 a difference of some 367 points. Ferguson Plc now has a 20 simple moving average of 5254.29 and now its 50 day moving average now at 5292.09. The market capitalisation currently stands at £11,677.37m at the time of this report. All share prices mentioned for this stock are traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Ferguson Plc being recorded at Tuesday, April 2, 2019 at 12:02:39 PM GMT with the stock price trading at 5034 GBX.

 

Shares in GlaxoSmithKline plc ticker code: LON:GSK has risen 1.08% or 17.1 points in today’s trading session so far. Investors have remained optimistic throughout the session. The high for the period has peaked at 1599.8 dropping as low as 1580.6. The total volume of shares exchanged so far has reached 1,664,673 with the daily average traded share volume around 8,662,868. The stock 52 week high is 1648.8 which is 66.8 points different to the previous business close and a 52 week low sitting at 1274.33 a difference of some 307.67 points. GlaxoSmithKline plc now has a 20 moving average of 1542.07 and now its 50 day simple moving average now of 1533.83. The market capitalisation is now £79,752.41m at the time of this report. The share price is in GBX. Mcap is measured in GBP. This article was written with the last trade for GlaxoSmithKline plc being recorded at Tuesday, April 2, 2019 at 12:03:59 PM GMT with the stock price trading at 1599 GBX.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    GSK's Jemperli receives FDA Breakthrough Therapy Designation for treating locally advanced dMMR/MSI-H rectal cancer, expediting crucial development.
    GSK announces FDA review of Nucala for COPD treatment following successful MATINEE study data, aiming to be the first approved monthly biologic.

      Search

      Search